Here is a breakdown of major shareholders in Oramed Pharmaceuticals, Inc (NASDAQ: ORMP)
Oramed Pharmaceuticals, Inc (NASDAQ: ORMP) is 26.41% higher on its value in year-to-date trading and has touched a low of $1.67 and a high of $5.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]